TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
INNV

InnovAge Holding Corp

Healthcare · Medical Care Facilities

10.90$ -1.4% vs. previous close Closing price · As of: Aug 19, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of InnovAge Holding Corp (INNV). It shows which part of the business is growing — and which one is holding it back.

Revenue by business segment

Revenue by business segment — INNV
Segment Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025 Q1 2026
PACE $204.9M 99.9% $208.8M 99.9% $217.9M 99.9% $235.8M 99.9% $239.7M 100.0% · +17.0% $251.9M 100.0% · +20.7%
All other $246.0K 0.1% $248.0K 0.1% $244.0K 0.1% $257.0K 0.1% $0 0.0% · -100.0% $0 0.0% · -100.0%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Revenue by product line

Revenue by product line — INNV
Segment Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025 Q1 2026
Capitation revenue $204.8M 99.8% $208.7M 99.8% $217.8M 99.9% $235.8M 99.9% $239.6M 100.0% · +17.0% $251.5M 99.8% · +20.5%
Other service revenue $342.0K 0.2% $325.0K 0.2% $323.0K 0.1% $354.0K 0.1% $88.0K 0.0% · -74.3% $441.0K 0.2% · +35.7%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.

Data as of: August 19, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?